Tracers / [18F]FP-CIT

[18F]FP-CIT

Also written as [18F]FP-CIT; [F-18]FP-CIT; F-18 FP-CIT; FP-CIT
Radionuclide
F-18 t½ 109.77 min
Modality
PET
Production route
Stage
Syntheses indexed
3

What it is

Compound class
Dopamine transporter (DAT) ligand (nortropane derivative)
Target / mechanism
Dopamine transporter (DAT) - striatal dopaminergic terminal density PMID 34414983
Clinical application
Dopamine transporter imaging in Parkinson's disease for assessment of nigrostriatal dopaminergic degeneration PMID 32134983
Theranostic pair

Regulatory status

FDA
EMA (centralised)
Other approvals
Brand names

Clinical use

Typical injected activity
Uptake time

Reported in the literature. Not a dosing recommendation.

Published syntheses

ModuleCassettePurificationYield %RCP %Precursor / supplierSource
34414983
2021 Medicine (Baltimore)
32134983
2020 PLoS One
HPLC42.5±10.9%
yes
21531297
2011 Nucl Med Biol
applied these conditions to automatic preparation with GE TracerLab FX module — We have 42.5±10.9% of decay corrected radiochemical yields

Need this precursor?We can point you to suppliers for [18F]FP-CIT, or handle the enquiry for you.

Get in touch

Quality control Preliminary — inferred from compound class

Ph. Eur. monograph
USP monograph
AppearancepHRCP HPLCRCP TLCHPLC UVRadionuclidic (HPGe)Half-lifeActivityEndotoxins (LAL)SterilityFilter integrity
How this set was arrived at. base set per Ph. Eur. general monograph 0125 (rule); organic-phase radiosynthesis assumed from isotope/compound class, no synthesis data confirming it -> GC residual solvents (preliminary); conventional nucleophilic 18F-fluorination assumed from isotope/compound class, no synthesis data confirming K222 use -> Kryptofix test (preliminary)

Tests listed by reference only. Monograph texts are copyrighted and are not reproduced here. How these are derived

Setting up quality control?We can help you scope the equipment needed to release [18F]FP-CIT.

Get in touch

Notes

Added from reverse module search (stage 6); 2 article(s) with F-18.